HCW Biologics Inc (NASDAQ: HCWB) open the trading on Wednesday, with great promise as it jumped 21.09% to $4.88, before settling in for the price of $4.03 at the close. Taking a more long-term approach, HCWB posted a 52-week range of $2.77-$100.80.
It was noted that the giant of the Healthcare sector posted annual sales growth of -29.55% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -29.55%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 91.82%. This publicly-traded company’s shares outstanding now amounts to $2.15 million, simultaneously with a float of $1.63 million. The organization now has a market capitalization sitting at $10.50 million. At the time of writing, stock’s 50-day Moving Average stood at $4.34, while the 200-day Moving Average is $8.84.
HCW Biologics Inc (HCWB) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. HCW Biologics Inc’s current insider ownership accounts for 24.25%, in contrast to 1.00% institutional ownership. According to the most recent insider trade that took place on May 16 ’25, this organization’s Chief Executive Officer bought 8,054 shares at the rate of 7.45, making the entire transaction reach 60,002 in total value, affecting insider ownership by 501,911. Preceding that transaction, on May 16 ’25, Company’s Director bought 1,342 for 7.45, making the whole transaction’s value amount to 9,998. This particular insider is now the holder of 4,075 in total.
HCW Biologics Inc (HCWB) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.77 per share during the current fiscal year.
HCW Biologics Inc’s EPS increase for this current 12-month fiscal period is 91.82% and is forecasted to reach -4.13 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 57.65% through the next 5 years, which can be compared against the -29.55% growth it accomplished over the previous five years trading on the market.
HCW Biologics Inc (NASDAQ: HCWB) Trading Performance Indicators
Let’s observe the current performance indicators for HCW Biologics Inc (HCWB). It’s Quick Ratio in the last reported quarter now stands at 0.11. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 12.65.
In the same vein, HCWB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -16.07, a figure that is expected to reach 1.58 in the next quarter, and analysts are predicting that it will be -4.13 at the market close of one year from today.
Technical Analysis of HCW Biologics Inc (HCWB)
[HCW Biologics Inc, HCWB] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 80.32% While, its Average True Range was 67.17.
Raw Stochastic average of HCW Biologics Inc (HCWB) in the period of the previous 100 days is set at 29.18%, which indicates a major fall in contrast to 100.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.24 that was lower than 0.48 volatility it exhibited in the past 100-days period.
